Dataset Information

First Complete Providencia rettgeri Genome Sequence, the NDM-1-Producing Clinical Strain RB151.

ABSTRACT: Providencia rettgeri is an opportunistic bacterial pathogen of clinical significance due to its association with urinary tract infections and multidrug resistance. Here, we report the first complete genome sequence of P. rettgeri The genome of strain RB151 consists of a 4.8-Mbp chromosome and a 108-kbp blaNDM-1-positive plasmid.

SUBMITTER: Marquez-Ortiz RA

PROVIDER: S-EPMC5255920 | biostudies-literature | 2017 Jan

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

First Complete Providencia rettgeri Genome Sequence, the NDM-1-Producing Clinical Strain RB151.

Marquez-Ortiz R Alejandro RA Haggerty Leanne L Sim Eby M EM Duarte Carolina C Castro-Cardozo Betsy E BE Beltran Mauricio M Saavedra Sandra S Vanegas Natasha N Escobar-Perez Javier J Petty Nicola K NK

Genome announcements 20170119 3

Providencia rettgeri is an opportunistic bacterial pathogen of clinical significance due to its association with urinary tract infections and multidrug resistance. Here, we report the first complete genome sequence of P. rettgeri The genome of strain RB151 consists of a 4.8-Mbp chromosome and a 108-kbp bla<sub>NDM-1</sub>-positive plasmid. ...[more]

PMID: 28104655

Similar Datasets

Project description:BACKGROUND:Providencia rettgeri is a nosocomial pathogen associated with urinary tract infections and related to Healthcare-Associated Infection (HAI). In recent years isolates producing New Delhi Metallo-?-lactamase (NDM) and other ?-lactamases have been reported that reduce the efficiency of clinical antimicrobial treatments. In this study, we analyzed antibiotic resistance, the presence of resistance genes and the clonal relationship of two P. rettgeri isolates obtained from male patients admitted to the same hospital in Bogotá - Colombia, 2015. RESULTS:Antibiotic susceptibility profile evaluated by the Kirby-Bauer method revealed that both isolates were resistant to third-generation carbapenems and cephalosporins. Whole-genome sequencing (Illumina HiSeq) followed by SPAdes assembling, Prokka annotation in combination with an in-house Python program and resistance gene detection by ResFinder identified the same six ?-lactamase genes in both isolates: blaNDM-1, blaVIM-2, blaCTX-M-15, blaOXA-10, blaCMY-2 and blaTEM-1. Additionally, various resistance genes associated with antibiotic target alteration (arnA, PmrE, PmrF, LpxA, LpxC, gyrB, folP, murA, rpoB, rpsL, tet34) were found and four efflux pumps (RosAB, EmrD, mdtH and cmlA). The additional resistance to gentamicin in one of the two isolates could be explained by a detected SNP in CpxA (Cys191Arg) which is involved in the stress response of the bacterial envelope. Genome BLAST comparison using CGView, the ANI value (99.99%) and the pangenome (using Roary) phylogenetic tree (same clade, small distance) showed high similarity between the isolates. The rMLST analysis indicated that both isolates were typed as rST-61,696, same as the RB151 isolate previously isolated in Bucaramanga, Colombia, 2013, and the FDAARGOS_330 isolate isolated in the USA, 2015. CONCLUSIONS:We report the coexistence of the carbapenemase genes blaNDM-1, and blaVIM-2, together with the ?-lactamase genes blaCTX-M-15, blaOXA-10, blaCMY-2 and blaTEM-1, in P. rettgeri isolates from two patients in Colombia. Whole-genome sequence analysis indicated a circulation of P. rettgeri rST-61,696 strains in America that needs to be investigated further.

Dataset Information

First Complete Providencia rettgeri Genome Sequence, the NDM-1-Producing Clinical Strain RB151.

Publications

First Complete Providencia rettgeri Genome Sequence, the NDM-1-Producing Clinical Strain RB151.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets